{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:28:12Z","timestamp":1789421292339,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>To survey persons with migraine who use social media about Complementary and Integrative Medicine (CIM) for the treatment of migraine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>CIM encompasses medical treatments that are not part of but are used in concert with mainstream medicine. Between 28 and 82% of people with migraine use non-drug approaches, and approximately 50% of people with migraine do not discuss non-drug treatments with their healthcare providers (HCPs). It is important for providers to be conversant with CIM treatments and the available evidence-based data. To further this effort, people with migraine were surveyed directly through social media to identify CIM practices in which they engage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In collaboration with the American Migraine foundation (AMF) and Yakkety Yak, a digital marketing agency, we conducted a cross-sectional survey study. Participants were recruited from the Move Against Migraine\u00a0(MAM) Facebook group which has 20,000+ members. The goals of the survey were to assess the attitudes toward CIM among this group, to identify which CIM modalities are being used and to determine what patients considered to be the most effective CIM modalities. While Yakkety Yak posted the survey link on the group page, the survey itself was hosted on Qualtrics, a confidential survey service.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>372 MAM members (approximately 2%) responded to the questionnaire, of which 335 reported using CIM; between 114 and 139 (34\u201342%) found CIM modalities to be at least mildly effective. Of note, 164 (49%) reported using cannabis derivatives or cannabinoids, specifically with, 64\/164 (39%) reporting that cannabis was not effective for them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides an initial investigation into the demographic and practice patterns of migraine patients who use CIM. While this sampling may not reflect CIM use across all individuals with migraine, it does strongly suggest the need for better education on the role of, and evidence for, CIM among headache care providers, and the need to ask patients specifically about their use of and interest in CIM.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12906-021-03226-0","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T07:37:45Z","timestamp":1613029065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey"],"prefix":"10.1186","volume":"21","author":[{"given":"Deena E.","family":"Kuruvilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Ravishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"3226_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/head.12482","volume":"55","author":"RC Burch","year":"2015","unstructured":"Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55:21\u201334.","journal-title":"Headache"},{"key":"3226_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1526-4610.2011.01917.x","volume":"51","author":"RE Wells","year":"2011","unstructured":"Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines\/severe headaches. Headache. 2011;51:1087\u201397.","journal-title":"Headache"},{"key":"3226_CR3","unstructured":"Website. Complementary, Alternative, or Integrative Health: What\u2019s In a Name? [https:\/\/nccih.nih.gov\/health\/integrative-health] Accessed on: 04 October 2019."},{"key":"3226_CR4","unstructured":"The Use and Cost of Complementary Health Approaches in the United States. https:\/\/www.nccih.nih.gov\/about\/the-use-and-cost-of-complementary-health-approaches-in-the-united-states."},{"key":"3226_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1212\/WNL.0b013e318287d94b","volume":"80","author":"A Mauskop","year":"2013","unstructured":"Mauskop A. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society. Neurology. 2013;80:868.","journal-title":"Neurology"},{"key":"3226_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ctcp.2017.12.003","volume":"30","author":"TG Rhee","year":"2018","unstructured":"Rhee TG, Harris IM. Reasons for and perceived benefits of utilizing complementary and alternative medicine in U.S. adults with migraines\/severe headaches. Complement Ther Clin Pract. 2018;30:44\u20139.","journal-title":"Complement Ther Clin Pract"},{"key":"3226_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/head.12986","volume":"57","author":"T Rhee","year":"2017","unstructured":"Rhee T. G. & Harris, I. M. gender differences in the use of complementary and alternative medicine and their association with moderate mental distress in U.S. adults with migraines\/severe headaches. Headache. 2017;57:97\u2013108.","journal-title":"Headache"},{"key":"3226_CR8","doi-asserted-by":"crossref","unstructured":"Kristoffersen AE, Stub T, Salamonsen A, Musial F, Hamberg K. Gender differences in prevalence and associations for use of CAM in a large population study. BMC Complementary Alternative Med. 2014;14:463. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4265502\/pdf\/12906_2014_Article_2034.pdf.","DOI":"10.1186\/1472-6882-14-463"},{"key":"3226_CR9","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.2196\/jmir.3229","volume":"16","author":"P Yuan","year":"2014","unstructured":"Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014;16:e117.","journal-title":"J Med Internet Res"},{"key":"3226_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.29262\/ram.v64i4.334","volume":"64","author":"JD Mart\u00ednez-Ezquerro","year":"2017","unstructured":"Mart\u00ednez-Ezquerro JD, Riojas-Garza A, Rend\u00f3n-Mac\u00edas ME. Clinical significance vs statistical significance. How to interpret the confidence interval at 95. Rev. Alerg. Mex. 2017;64:477\u201386.","journal-title":"Rev. Alerg. Mex"},{"key":"3226_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s40064-016-2362-7","volume":"5","author":"J Lee","year":"2016","unstructured":"Lee J, Bhowmick A, Wachholtz A. Does complementary and alternative medicine (CAM) use reduce negative life impact of headaches for chronic migraineurs? A national survey. Springerplus. 2016;5:1006.","journal-title":"Springerplus"},{"key":"3226_CR12","volume-title":"in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institute of Diabetes and Digestive and Kidney Diseases","author":"Butterbur","year":"2019","unstructured":"Butterbur. in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institute of Diabetes and Digestive and Kidney Diseases, 2019)."},{"key":"3226_CR13","unstructured":"Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Report. 2008;12:1\u201323."},{"key":"3226_CR14","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s00415-010-5616-2","volume":"257","author":"RE Wells","year":"2010","unstructured":"Wells RE, Phillips RS, Schachter SC, McCarthy EP. Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol. 2010;257:1822\u201331.","journal-title":"J Neurol"},{"key":"3226_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.amjcard.2006.03.051","volume":"98","author":"GY Yeh","year":"2006","unstructured":"Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006;98:673\u201380.","journal-title":"Am J Cardiol"},{"key":"3226_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/oby.2008.239","volume":"16","author":"SM Bertisch","year":"2008","unstructured":"Bertisch SM, Wee CC, McCarthy EP. Use of complementary and alternative therapies by overweight and obese adults. Obesity. 2008;16:1610\u20135.","journal-title":"Obesity"},{"key":"3226_CR17","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1111\/j.1526-4610.2005.4502001.x","volume":"45","author":"DB Penzien","year":"2005","unstructured":"Penzien DB. Guidelines for trials of Behavioral treatments for recurrent headache: purpose, process, and product. Headache. 2005;45:S87\u20139.","journal-title":"Headache"},{"key":"3226_CR18","volume-title":"Behavioral and Physical Treatments for Migraine Headache. Agency for Health Care Policy and Research (US)","author":"RE Goslin","year":"2010","unstructured":"Goslin, R. E. et al. Behavioral and Physical Treatments for Migraine Headache. Agency for Health Care Policy and Research (US), 2010)."},{"key":"3226_CR19","volume-title":"Dioscorides Pedanius of & Gunther, R. T. The Greek Herbal of Dioscorides: Illustrated by a Byzantine A.D. 512, Englished by John Goodyer A.D. 1655, Edited and First Printed A.D. 1933","author":"CE Dubler","year":"1968","unstructured":"Dubler CE. Dioscorides Pedanius of & Gunther, R. T. The Greek Herbal of Dioscorides: Illustrated by a Byzantine A.D. 512, Englished by John Goodyer A.D. 1655, Edited and First Printed A.D. 1933; 1968."},{"key":"3226_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2009.06.021","volume":"461","author":"G Juhasz","year":"2009","unstructured":"Juhasz G, et al. Variations in the cannabinoid receptor 1 gene predispose to migraine. Neurosci Lett. 2009;461:116\u201320.","journal-title":"Neurosci Lett"},{"key":"3226_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nbd.2008.01.003","volume":"30","author":"LM Cupini","year":"2008","unstructured":"Cupini LM, et al. Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiol Dis. 2008;30:186\u20139.","journal-title":"Neurobiol Dis"},{"key":"3226_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5737\/23688076292123131","volume":"29","author":"C Page","year":"2019","unstructured":"Page C, Cordon C, Wong J. Evaluating the effectiveness of a mnemonic to guide staff when providing patient education to autologous hematopoietic stem cell transplant patients. Can Oncol Nurs J. 2019;29:123\u201331.","journal-title":"Can Oncol Nurs J"},{"key":"3226_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1001\/jama.279.19.1548","volume":"279","author":"JA Astin","year":"1998","unstructured":"Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279:1548\u201353.","journal-title":"JAMA"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03226-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-021-03226-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03226-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T01:14:09Z","timestamp":1724462049000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-021-03226-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3226"],"URL":"https:\/\/doi.org\/10.1186\/s12906-021-03226-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Yale University ethics committee approved this study. Written, electronic consent was obtained before participants could move forward to complete the survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We provide consent to BMC Complementary and Alternative Medicine for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have disclosures related to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}